Abstract:Introduction Natural Killer (NK) cells hold the potential to shift cell therapy from a complex autologous option to a universal off-the-shelf one. Although NK cells have demonstrated efficacy and safety in the treatment of leukemia, the limited efficacy of NK cell-based immunotherapies against solid tumors still represents a major hurdle. In the immunosuppressive tumor microenvironment (TME), inhibitory interactions between cancer and immune cells impair antitumoral immunity. KLRC1 gene encodes the NK cell inhibitory receptor NKG2A, which is a potent NK cell immune checkpoint. NKG2A specifically binds HLA-E, a non-classical HLA class I molecule frequently overexpressed in tumors, leading to the transmission of inhibitory signals that strongly impair NK cell function. Methods To restore NK cell cytotoxicity against HLA-E + tumors, we have targeted the NKG2A/HLA-E immune checkpoint by using a CRISPR-mediated KLRC1 gene editing. Results KLRC1 knockout resulted in a reduction of 81% of NKG2A + cell frequency in ex vivo expanded human NK cells post-cell sorting. In vitro , the overexpression of HLA-E by tumor cells significantly inhibited wild-type (WT) NK cell cytotoxicity with p -values ranging from 0.0071 to 0.0473 depending on tumor cell lines. In contrast, KLRC1 KO NK cells exhibited significantly higher cytotoxicity when compared to WT NK cells against four different HLA-E + solid tumor cell lines, with p -values ranging from<0.0001 to 0.0154. Interestingly, a proportion of 43.5% to 60.2% of NKG2A − NK cells within the edited NK cell population was sufficient to reverse at its maximum the HLA-E-mediated inhibition of NK cell cytotoxicity. The expression of the activating receptor NKG2C was increased in KLRC1 KO NK cells and contributed to the improved NK cell cytotoxicity against HLA-E + tumors. In vivo , the adoptive transfer of human KLRC1 KO NK cells significantly delayed tumor progression and increased survival in a xenogeneic mouse model of HLA-E + metastatic breast cancer, as compared to WT NK cells ( p = 0.0015). Conclusions Our results demonstrate that KLRC1 knockout is an effective strategy to improve NK cell antitumor activity against HLA-E + tumors and could be applied in the development of NK cell therapy for solid tumors.

Klrl1, A Novel Killer Cell Lectinlike Receptor, Inhibits Natural Killer Cell Cytotoxicity

Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.

Structure of the human NK cell NKR-P1:LLT1 receptor:ligand complex reveals clustering in the immune synapse

mKLRL1 regulates the maturation of dendritic cells and plays important roles in immune tolerance.

The role of KLRG1: a novel biomarker and new therapeutic target

Identification of a novel type I cytokine receptor CRL2 preferentially expressed by human dendritic cells and activated monocytes

KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Functional Consequences of Interactions Between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells

The Lectin-Like Receptor Ly49s3 of Rat Natural Killer Cells

A multigene family on human chromosome 12 encodes natural killer-cell lectins

Natural Killer Lytic-Associated Molecule (NKLAM): An E3 Ubiquitin Ligase With an Integral Role in Innate Immunity

KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors

Natural killer cell cytotoxicity and its regulation by inhibitory receptors

Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes

Killer Immunoglobulin-Like Receptors/human Leukocyte Antigen Class-I, a Crucial Immune Pathway in Cancer

Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors

Expression of a single inhibitory member of the Ly49 receptor family is sufficient to license NK cells for effector functions

A Long Noncoding RNA Positively Regulates CD56 in Human Natural Killer Cells.

KLRG 1 Negatively Regulates Natural Killer Cell Functions Through the Akt Pathway in Individuals with Chronic Hepatitis C Virus Infection

Chemokine (C-X-C motif) ligand 1 maintains the immune surveillance function of natural killer cells via the PDK2/mTOR signaling pathway

KLRG1 restricts memory T cell antitumor immunity.